Basista Prasad Rijal

Basista Prasad Rijal

Auto-generated profile, based on publicly available information

Basista Prasad Rijal

Department of Clinical Microbiology, Manmohan Memorial Medical College and Teaching Hospital, Kathmandu, Nepal

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2017 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
NPNarayan Prasad Parajuli
Narayan Prasad Parajuli
SASubhash Prasad Acharya
Subhash Prasad Acharya
SMShyam Kumar Mishra
Shyam Kumar Mishra
KPKeshab Parajuli
Keshab Parajuli
BRBasista Prasad Rijal
Basista Prasad Rijal
BPBharat Mani Pokhrel
Bharat Mani Pokhrel
Healthcare associated infections (HCAI) and antimicrobial resistance are principal threats to the patients of intensive care units and are the major determining factors for patient outcome. They are associated with increased morbidity, mortality, excess hospitalization and financial costs. The present study is an attempt to investigate the spectrum and antimicrobial resistance of bacterial isolates involved in healthcare associated infections (HCAI) in the patients of a critical care unit at a tertiary care university hospital in Kathmandu, Nepal. A laboratory based study was conducted over the period of 15 months (January 2014 to March 2015) among the patients of intensive care unit of Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Clinical specimens from patients with suspected healthcare-associated infection were processed and bacterial isolates were identified with standard microbiological methods. Antimicrobial susceptibilities of the isolated strains were determined according to the CLSI guidelines and β-lactamases (ESBL, AmpC, MBL and KPC) were detected by various phenotypic tests. One hundred and forty nine clinical specimens received from 135 patients suspected of HCAI (out of 491 patients) were found with significant bacterial growth. Specimens were from patients suspected of hospital-acquired pneumonia (16%, 79/491), bloodstream infections (5.7%, 28/491), surgical site infections (4.7%, 23/491), and urinary tract infections (3.9%, 19/491). Acinetobacter spp., Klebsiella spp., Escherichia coli and Burkholderia cepacia were the leading bacterial pathogens. Extremely high level of drug resistance (95.8%) along with the production of β-lactamases (ESBL; 43.7%, AmpC; 27.5%), MBL; 50.2% and KPC; 4.2%) was observed among Gram negative bacterial isolates. Healthcare associated infections are very common in our ICU. Gram negative bacterial pathogens are major culprits associated with these infections and there is alarming state of drug resistance among these isolates. Continuous surveillance and establishment of preventive and control measures of healthcare associated infections are urgently needed in our setting.

15 April 2020 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
Roshan PanditRoshan Pandit
Roshan Pandit
BABalkrishna Awal
Balkrishna Awal
SSSumesh Shreekhanda Shrestha
Sumesh Shreekhanda Shrestha
GJGovardhan Joshi
Govardhan Joshi
BRBasista Prasad Rijal
Basista Prasad Rijal
NPNarayan Prasad Parajuli
Narayan Prasad Parajuli
Urinary tract infections (UTI) represent the most common bacterial infections among patients visiting outpatient clinics of healthcare centers in Nepal. However, treatment of such infections is compounded by emergence and spread of multidrug-resistant uropathogens associated with extended-spectrum β-lactamases (ESBLs). In this study, we aimed to investigate the burden of antimicrobial resistance and occurrence of ESBL genes among clinical isolates of uropathogenic Escherichia coli at a tertiary care teaching hospital of Nepal. During the study period, we processed a total of 1,626 urinary tract specimens, isolated significant bacterial pathogens, and investigated their antimicrobial susceptibilities. Escherichia coli (n = 154), the predominant pathogen associated with UTI, was further investigated for the existence of ESBL enzymes by using conventional phenotypic as well as molecular approaches. Among suspected cases of UTI, we found that 15.2% were having UTI and female patients of the reproductive age group were more affected (p<0.05). Escherichia coli (154, 62.1%) was the key uropathogen, and majority (∼64.9%) of them were multidrug resistant (MDR). Among MDR E. coli isolates, 40.3% were producing extended-spectrum β-lactamases (ESBLs). bla-TEM (83.8%), bla-CTX-M (66.1%), and bla-SHV (4.8%) were common ESBL genotypes. Nitrofurantoin, gentamycin, and imipenem were the most effective antibiotics for ESBL-producing Escherichia coli isolates. It indicates that the high rates of multidrug-resistant Escherichia coli are frequent causes of UTI in our hospital. Nitrofurantoin and aminoglycosides are the most useful first-line drugs to be used in the cases of UTI. We recommend the regular investigation of drug resistance among all isolates and develop a useful antibiotic prescription policy in our country.

20 September 2014 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
SMShyam Kumar Mishra
Shyam Kumar Mishra
PBPrashant Basukala
Prashant Basukala
OBOm Basukala
Om Basukala
KPKeshab Parajuli
Keshab Parajuli
BPBharat Mani Pokhrel
Bharat Mani Pokhrel
BRBasista Prasad Rijal
Basista Prasad Rijal

1 November 2015 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
SSShovita Shrestha
Shovita Shrestha
TTTatsuya Tada
Tatsuya Tada
TMTohru Miyoshi-Akiyama
Tohru Miyoshi-Akiyama
HOHiroshi Ohara
Hiroshi Ohara
KSKayo Shimada
Kayo Shimada
BPBharat Mani Pokhrel
Bharat Mani Pokhrel

24 June 2017 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Sundar KhadkaSundar Khadka
Sundar Khadka
JSJeevan Bahadur Sherchand
Jeevan Bahadur Sherchand
BPBharat Mani Pokhrel
Bharat Mani Pokhrel
KPKeshab Parajuli
Keshab Parajuli
SMShyam Kumar Mishra
Shyam Kumar Mishra
BRBasista Prasad Rijal
Basista Prasad Rijal
Candida species are responsible for various clinical infections ranging from mucocutaneous infection to life threatening invasive diseases along with increased resistance to antifungal drugs has made a serious concern. Resistance to antifungal agents has increased during the last decade. Thus, identification of Candida up to species level and its antifungal susceptibility testing has a paramount significance in the management of Candidal infections. The aim of the study was to speciate Candida species and to determine antifungal susceptibility pattern of Candida species to antifungal agents. A total of 100 consecutive Candida species were isolated from 1248 clinical specimens over 7 months period. Growths on Sabouraud dextrose agar were evaluated for colony appearance, macroscopic examination, Gram staining, germ tube test and urea hydrolysis test. Further, they were processed for Candida speciation on CHROMagar. Antifungal susceptibility testing was performed as recommended by Clinical and Laboratory Standards Institute (CLSI) M44-A document. Out of 100 Candida isolates, Candida albicans (56%) was the most common species. Among the non-albicans Candida species, Candida tropicalis (20%) was the predominant isolate followed by Candida glabrata (14%). Regarding antifungal susceptibility pattern, Candida species were more susceptible to clotrimazole (82%) followed by fluconazole (64%) and miconazole (44%). Candida albicans was the predominant species responsible for various Candidal infections. Among commonly used antifungal drugs clotrimazole, miconazole and fluconazole were most effective.

15 March 2013 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
SMShyam Kumar Mishra
Shyam Kumar Mishra
BRBasista Prasad Rijal
Basista Prasad Rijal
BPBharat Mani Pokhrel
Bharat Mani Pokhrel
Infections caused by bacteria such as multidrug resistant (MDR) Acinetobacter spp. and methicillin-resistant Staphylococcus aureus (MRSA) constitute a worldwide pandemic. Without gathering information about these strains, we cannot reduce the morbidity and mortality due to infections caused by these notorious bugs.